NEW YORK, NY — As the world dons pink ribbons for Breast Cancer Awareness Month this October, a global movement is working to ensure that the most critical, terminal form of the disease is not left in the shadows. On October 13, 2026, National Metastatic Breast Cancer Awareness Day, more than 325 landmarks across the globe will transition from the traditional pink of early detection to the teal, green, and pink of metastatic breast cancer (MBC) awareness.
The campaign, titled #LightUpMBC, is organized by METAvivor Research and Support, a non-profit dedicated to funding research for Stage 4 breast cancer. This year’s initiative marks a historic peak in advocacy, spanning all 50 U.S. states and 20 countries, aimed at transforming the public’s understanding of a disease that currently claims the lives of approximately 117 people in the United States every single day.
Main Facts: A Global Spectrum of Awareness
Metastatic breast cancer, also known as Stage 4, occurs when cancer cells break away from the primary tumor in the breast and travel through the lymphatic system or bloodstream to other parts of the body. Most commonly, MBC settles in the bones, liver, lungs, or brain. Unlike early-stage breast cancer, MBC is currently incurable.
The #LightUpMBC campaign serves as a visual and digital rallying cry for the estimated hundreds of thousands of people living with the disease worldwide. By illuminating iconic structures in its signature colors—teal for the community, green for hope and renewal, and pink for the origins of the disease—the campaign seeks to bridge the gap between general awareness and the urgent need for life-extending research.
Key Components of the 2026 Campaign:
- Scale of Participation: Over 325 landmarks in 195 cities will participate, including world-renowned sites such as One World Trade Center in New York, the Willis Tower in Chicago, and the Mactan-Cebu Airport in the Philippines.
- The Live Broadcast: The centerpiece of the evening is "#LightUpMBC Live," a virtual event streaming at 8 p.m. ET. The program features a blend of scientific discourse, patient testimonials, and high-profile musical performances.
- Funding Commitment: 100% of the net proceeds from the campaign are funneled directly into Stage 4 research grants. To date, the movement has raised over $2.7 million for MBC-specific studies.
Chronology: From a Single Bridge to a Global Phenomenon
The evolution of #LightUpMBC is a testament to the power of grassroots advocacy and the legacy of those lost to the disease. The movement’s origins can be traced back to 2017, rooted in a personal promise between friends.
2017: The First Light
The campaign was founded by Laura Inahara in honor of her best friend, Jessica Moore. Moore was diagnosed with MBC at the age of 32 and passed away just four years later. Her simple wish was to see a single local landmark lit up in MBC colors to bring attention to the specific needs of Stage 4 patients. In October 2017, the Memorial Bridge in Portsmouth, New Hampshire, became the first landmark to illuminate for the cause.
2018–2022: Rapid Expansion
Following the success in New Hampshire, the campaign gained traction through social media and patient networks. METAvivor adopted the initiative as a flagship awareness event. By 2020, despite the global pandemic, the campaign pivoted to a digital-heavy format, introducing the first "#LightUpMBC Live" stream to connect a geographically isolated patient community.
2023–2026: A Global Standard
By 2026, the campaign has matured into a sophisticated international operation. What began as a tribute in a small New England town now encompasses major capitals and transit hubs across 20 countries, including the United Kingdom, Canada, and the Philippines. The inclusion of sites like Niagara Falls and Philadelphia City Hall underscores the campaign’s shift from a niche advocacy group to a mainstream philanthropic force.
Supporting Data: The Stark Reality of MBC in 2026
The necessity for #LightUpMBC is underscored by sobering statistics provided by the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) program. While advancements in early-stage treatment have improved overall survival rates for breast cancer, the statistics for metastatic disease remain a challenge for the medical community.
Mortality and Diagnosis
In 2026, an estimated 42,670 people in the U.S. are expected to die from breast cancer. Virtually all of these deaths are the result of metastatic disease.
- Daily Toll: Approximately 117 deaths occur daily due to MBC complications.
- De Novo vs. Recurrence: While some patients are diagnosed with Stage 4 from the outset (de novo), many others experience a recurrence years or even decades after being told they were "cancer-free" following treatment for early-stage disease.
- The Funding Gap: Historically, only a small fraction of overall breast cancer research funding (estimated between 2% and 7%) has been directed toward metastatic research, with the majority focused on prevention and early detection.
The Financial Impact of Advocacy
Since its inception, the #LightUpMBC campaign has raised over $2.7 million. These funds are critical because METAvivor remains one of the few organizations that exclusively funds Stage 4 research. By focusing 100% of net proceeds on metastatic-specific grants, the organization addresses the specific biological mechanisms of how cancer spreads and how it becomes resistant to existing therapies.
Official Responses: Voices from the Frontlines
The 2026 campaign is led by individuals who occupy the unique intersection of medical expertise and lived experience. Their perspectives highlight why this specific day of awareness is vital for the patient community.
Dr. Kelly Shanahan, METAvivor Board President, who has been living with MBC since 2013, emphasizes the role of longevity through science. “When I was diagnosed… I certainly didn’t think I’d still be here 13 years later,” Dr. Shanahan stated. “My hope and the hope of so many others lies in research. #LightUpMBC is the biggest contributor to this research and is also a way to bring us together as a community.”
Laura Inahara, Founder of #LightUpMBC, reflected on the growth of the movement in memory of her friend Jessica Moore. “Jessica’s legacy helps families around the world shine a light for the people they love, teach patients with MBC how to advocate for themselves, and has now raised over $2.7 million for critical MBC research.”
The 2026 live broadcast will be hosted by Tami Eagle Bowling, a creator and advocate living with MBC for 11 years, alongside Broadway performer Kara Lindsay. The inclusion of high-caliber talent—such as Tony Award winner Victoria Clark and Tony nominee Dorian Harewood—serves to elevate the disease’s profile to a broader audience, moving beyond the medical community into the cultural zeitgeist.
Implications: Changing the Narrative of Breast Cancer
The #LightUpMBC campaign has profound implications for how society views breast cancer. For decades, the "Pink Ribbon" narrative has focused heavily on "survivorship," often defined as finishing treatment and moving on. For the MBC community, treatment never ends.
Redefining Survivability
The ultimate goal of METAvivor and the #LightUpMBC campaign is to shift the medical classification of MBC from a "terminal disease" to a "survivable chronic condition." This shift requires a continuous pipeline of new therapies to stay ahead of the cancer’s ability to mutate and resist drugs. By funding research that focuses on "stable disease" and quality of life, the campaign is helping to rewrite the prognosis for thousands.
The Power of "Teal, Green, and Pink"
The visual shift from pink to the tri-color palette of MBC awareness is a symbolic act of inclusion. Many Stage 4 patients report feeling "erased" during Breast Cancer Awareness Month, as their reality does not fit the optimistic "early detection saves lives" mantra. #LightUpMBC provides a space where the realities of treatment fatigue, scanxiety, and grief are acknowledged alongside hope.
A Call to Global Action
As the sun sets on October 13, 2026, the glow from hundreds of landmarks will serve as a reminder that awareness is only the first step. The campaign encourages the public to take tangible action by photographing these landmarks and sharing them with the hashtags #LightUpMBC and #METAvivor.
In a world where 117 people are lost every day to this disease, the lights in New York, Chicago, London, and Cebu are more than just a tribute—they are a demand for the research necessary to ensure that one day, no one dies from breast cancer.
How to Participate:
- Watch: Tune in to #LightUpMBC Live at 8 p.m. ET / 5 p.m. PT on the METAvivor YouTube and Facebook channels.
- Locate: Find a participating landmark near you at www.lightupmbc.org.
- Donate: Support Stage 4 research by visiting the METAvivor website. 100% of your donation goes toward metastatic breast cancer research grants.
About the Author
